News & publications
Stay updated on the most recent developments in Symeres
High-throughput screening is a powerful tool to start drug-discovery programs. The success of this activity is highly dependent on the quality of the library that is screened. With this in mind, Symeres created the SymeGold library, which features compounds with a high degree of three-dimensionality.
At Symeres, we’re always looking to support our clients with novel and innovative ideas. Dr. André de Vries joined our ranks as of January 1, 2022.
In 2016, Stefan Krauss and Jo Waaler (University Hospital of Oslo, Norway) approached Symeres to optimize […]
Richard Baauw joined Symeres in 2017, along with his company Chiralix. Chiralix focused on the synthesis of optically active compounds.